Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Selective Serotonin Reuptake Inhibitor Drugs Alter Retinal Nerve Fiber Layer Thickness in First Episode Depressive Patients?

NCT04717921 is registered in ClinicalTrials.gov with Mehmet Diyaddin Güleken as lead sponsor.

NCT NCT04717921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04717921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Selective Serotonin Reuptake Inhibitor Drugs Alter Retinal Nerve Fiber Layer Thickness in First Episode Depressive Patients?
Lead sponsor
Mehmet Diyaddin Güleken
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2020
Completion date
September 1, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unipolar depression